Clinical Trials Logo
  1. Home
  2. Vulvar Squamous Cell Carcinoma
  3. NCT01500512

Observation in Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node Dissection — GROINSS-V  

Vulvar Squamous Cell Carcinoma Clinical Trial

Official title:
GROningen INternational Study on Sentinel Nodes in Vulvar Cancer (GROINSS-V) II: An Observational Study

Clinical Trial Summary

This research trial studies patients with early-stage vulvar cancer undergoing sentinel lymph node dissection. Sentinel lymph node dissection may have fewer side effects than removing all lymph nodes. Observing patients undergoing sentinel lymph node dissection may help doctors confirm the safety of the procedure.

Clinical Trial Description

PRIMARY OBJECTIVES: I. To prospectively observe patients who receive radiation +/- chemotherapy immediately after lymph node dissection to confirm the safety of this procedure. OUTLINE: Patients receive standard therapy including sentinel lymph node dissection. Patients are then observed to collect information about treatment and outcomes every 2 months for 2 years. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01500512
Study type Observational
Source GOG Foundation
Contact
Status Active, not recruiting
Phase
Start date January 3, 2012
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02978625 - Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers Phase 2
Active, not recruiting NCT02140021 - Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer N/A
Not yet recruiting NCT06358469 - STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision N/A
Completed NCT00897442 - Collecting Tumor Samples From Patients With Gynecological Tumors N/A
Recruiting NCT04430699 - Cisplatin+Pembrolizumab+RT in Vulvar Cancer Phase 2
Active, not recruiting NCT01595061 - Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva Phase 2
Completed NCT03452332 - Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers Phase 1
Completed NCT00068406 - Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva Phase 2
Recruiting NCT04761146 - A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva Cancer N/A